The majority of patients with Parkinson's disease (PD) can be treated with medications. As the disease progresses, however, certain symptoms may evolve that are refractory to medical therapy but ideally suited to surgical intervention. Tremor, dyskinesia and motor fluctuation can be effectively treated with deep brain stimulation (DBS). This article highlights which PD patients can benefit from DBS and summarises how the operations are performed and what are the expected outcomes (and potential complications). The relevant literature is reviewed for experienced clinicians and our personal bias is highlighted for those new to the field (and hoping to avoid our early mistakes).
The selection of the ideal patient, however, is much more difficult and is as much an art as a science. This article will summarise how DBS can be used to help patients with PD. The relevant literature will be presented for a comprehensive overview but we will focus on our personal experience (and bias) to provide practical guidelines. Each of the three main brain targets for this technique will be discussed and suggestions on patient selection, surgical technique, post-operative care and expected outcomes will be provided.
The current popularity and wide acceptance of DBS for PD began in the early 1990s. Publications from the teams in Grenoble  1,2 and Lille   3 re-ignited interest in this technique after earlier publications had introduced the concept of DBS for PD but had not gained wide acceptance. 4 The concept that DBS could create a beneficial clinical effect without destroying tissue was very appealing. Prior to this technology, neurosurgeons could only destroy target areas in the brain.
A variety of structures had been lesioned in an attempt to ameliorate PD, including the motor cortex, 5, 6 the spinal cord motor pathways 7 and the basal ganglia. 8 The early experience (prior to 1960) was fraught with morbidity and mortality. 9 The more recent experience has been aided by accurate neuroimaging, intra-operative electrophysiological confirmation of targeting and reproducible lesioning. During thalamotomy, macrostimulation of the ventral intermediate nucleus (Vim) with high-frequency stimulation (100 Hz) was known to block contralateral tremor whereas 'low'-frequency stimulation (50 Hz) drove the tremor. 2 Permanent implantation of an electrode to chronically stimulate the Vim at high frequency was proposed to suppress tremor 2 and tested as a method to avoid the complications associated with bilateral thalamotomy. 1, 10, 11 Following a unilateral Vim thalamotomy, the contralateral side could be treated with DBS. Beneficial effects (i.e.
blocking tremor) were obtained by increasing the voltage of stimulation and deleterious side effects (e.g. dysarthria) were avoided by reducing the voltage. The effect of DBS could be titrated.
The ability to titrate the effect of DBS has remained its greatest asset.
Adjusting the effect of DBS post-operatively to gain more benefit in a progressive disease or back away from a side effect is appealing to both the surgeon and patient. The concept that 'we have not burned any bridges' is also very appealing to many potential patients.
Prospective patients often arrive for their surgical consultation emboldened by the concept that the surgeon is 'only' inserting an electrode in their brain and not burning any tissue. The review of potential risks of DBS is often surprising for the patients and is an essential part of their pre-operative assessment.
With the success of Vim DBS in reducing tremor following contralateral thalamotomy, it was not long before DBS was used primarily to treat tremor without any prior thalamotomy. 2 DBS appeared to work like a reversible lesion and was therefore tried in the pallidum instead of pallidotomy. 12 At this time, surgeons began exploring the subthalamic nucleus (STN) as a target for PD and DBS was used in this target prior to any significant experience with lesions in this target. 13, 14 How DBS exerts its effects remains controversial. 9, [15] [16] [17] [18] [19] [20] Since high-frequency DBS in the thalamus or pallidum had similar clinical effects to lesions, it was assumed that DBS worked by inhibiting neuronal firing. This reasoning was used to support surgeons targeting the STN, which had been shown to be overactive in primate models of PD. 21, 22 More recently, however, it has become clear that the effect is probably more complex. 9 DBS may work by desynchronising pathological rhythms in the basal ganglia. 23 DBS brings a new set of problems to the management of PD.
There are complications associated with surgery (brain haemorrhage and infection), 9,24-28 stimulation-related and neuropsychiatric issues, 29, 30 there is the need for intensive follow-up care to adjust the stimulation and the technology is expensive. Nonetheless, the ideal patient receiving the ideal operation can enjoy stunning benefits. [31] [32] [33] It all begins with selecting the correct patient.
34-38

Patient Selection
The surgeon must aim to improve the quality of life of their patient not just reduce a given symptom.
The majority of patients with PD are adequately managed with medications. 39 A small portion of patients, however, will have medically refractory symptoms that can be ameliorated with surgery. The selection of these patients is just as important as the performance of surgery in determining the final outcome. The general neurosurgeon does not require help assessing the need for surgery in a patient with a traumatic epidural haematoma or tumour causing brain herniation.
What is the alternative? The functional neurosurgeon, however, must be satisfied that the medical alternatives have failed before considering surgery. This presents a problem for the neurosurgeon unfamiliar with PD medications. The solution in many centres has been a close collaboration between the neurosurgeon, neurologist and other specialists. 33, 34, 40 This is a recurring theme in DBS for PD -it requires a team to deliver ideal care. Tremor occurs at rest but can become exhausting. The tremor will dampen on the initiation of movement but, as the arm is held still for any activity (e.g. holding a cup to the lips), the arm will shake again. This tremor can be present in the upper and lower limb as well as the jaw and body.
What degree of tremor is intolerable will depend entirely on the patient.
The retired teacher can tolerate more tremor than when they were working. Our policy has been to defer to the patient but, in general, we would consider thalamic DBS once the tremor interferes with employment or activities of daily living such as eating, personal hygiene or dressing.
The selection of left, right or bilateral procedures is entirely individual. In general, we recommend a unilateral procedure for the dominant hand in patients who have retired from working (typically aged 65). After six months to a year, the patient will know the result of what their thalamic DBS can do and how it affects their unique activities. If they want the opposite side done, they can have it as a staged procedure. For patients still in the workforce, a bilateral procedure is often performed initially.
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The first few years of medical treatment of PD can often produce excellent results. 39 Patients feel dramatically better on medications and are not disabled. As the disease progresses, however, new complications emerge: dyskinesia and motor fluctuations. 39, 48, 49 Dyskinesia is a side effect of dopaminergic stimulation. Its aetiology is unknown but its manifestations are unmistakable. Patients can be affected over a wide range of severity. Mild dyskinesia is a smooth, near-constant movement perhaps best described as wiggling (like a bored young child) and can be deliberately hidden by patients within normal movements (e.g. adjusting clothing). The patient may become unaware of this movement but the spouse can often notice it. Dyskinesia can gradually increase in severity (it is measured on a scale of 0-4) 50 and patients find moderate dyskinesia intrusive. At this stage, patients will often walk with their arm(s) pulled behind them in a writhing movement. Severe dyskinesia is ballistic and dangerous. Patients can throw themselves out of a chair, injure bystanders and find the constant movement exhausting. They will lose weight from the constant exercise and any joint simultaneously affected with arthritis will be excruciatingly painful. The first treatment for dyskinesia is to reduce the PD medications. 51 Reduced medications, however, will produce more bradykinetic symptoms (unless initially overdosed) and patients will invariably choose dyskinesia over bradykinesia. For the patient with disabling dyskinesia superimposed upon otherwise good control of their motor symptoms, globus pallidus DBS is an option. This treatment requires the neurologist to maintain the PD medications (and even increase if necessary) to manage mobility, while the globus pallidus DBS controls the dyskinesia. The neurologist is free to push medications harder because the previous limiting side effects (dyskinesia) have been removed by the DBS.
Motor Fluctuations (Subthalamic Deep Brain Stimulation)
The beneficial effect of a given dosage of PD medication tends to last for a shorter period as the disease progresses. 52 This is initially overcome by shortening the dosage interval. Eventually some patients are taking their PD medications every three hours and still not getting consistent benefit. They usually report that it takes a variable amount of time for the medications to start working (30-60 minutes after swallowing), then they get benefit for an hour which then starts to wear off before the next dosage. Patients will therefore fluctuate in their symptoms from bradykinetic-rigid to moving well to peak-dose dyskinesia, then back to moving well and finally bradykinetic-rigid.
This cycle is repeated with each dose. This pattern is called motor fluctuations 39 and can be ideally treated with STN DBS.
It is our opinion that the effect of STN DBS mimics that of dopaminergic medication except that it can be applied smoothly throughout the day instead of in dosing intervals. The ideal patient will therefore have enjoyed a good response to dopaminergic medications pre-operatively.
That response may be partially obscured by dyskinesia or motor fluctuations but there must be one moment in a typical day when the patient has a good response to the medications. If that is the case, then STN DBS will be able to 'capture' that moment and extend it longer throughout the day. Patients will not have a better motor function than before surgery; they will just spend more time at that best level of stereotaxis. 63 We acknowledge that there are many centres producing excellent work with frameless technology [64] [65] [66] [67] [68] and remember that all of our early work was carried out with ventriculography and computed tomography (CT) guidance. Movement Disorders Parkinson's Disease
realign the brain so that the AC and PC lie on the same axial plane (regardless of how the frame was applied). Moving away from the MCP towards the target can then be performed accurately because the frame has not introduced a pitch, roll or yaw error. 72, 88, 89 Prior to neuronavigational computers, it was crucial to apply the frame parallel to the AC-PC to avoid these errors. We believe it continues to be good practice to place the frame orthogonal to the AC-PC line, using the glabella-inion or infra-orbital-meatal lines as a guide. Secondly, it allows a trial of virtual electrode passes through the brain to determine if any would pass through a blood vessel, sulcus or ventricle. 88 We perform a thin-cut T1-weighted sequence with gadolinium and use a 'probe's eye view' to ensure no vessel would be hit during our electrode pass. This step is time-consuming but is probably the single most important improvement in technique over the last decade that has reduced complications.
During the surgery, there are a set of common surgical techniques regardless of the target and some specific nuances for each. It is our practice to place patients supine on the operating table, flexed at the hips and knees and head elevated with the skull at the entry site almost horizontal. This places the skull above the heart and risks venous air emboli when close to the midline (thalamic approach). In one review, 90 the incidence of air embolism was reported to be up to 3.2 %. Clinically symptomatic emboli, however, are rarely reported. 91, 92 In our experience, if emboli occur, the awake patient will begin to clear their throat (and describe a tickle in their throat) and later cough. This occurs concurrently when, or slightly before, a pre-cordial Doppler detects the emboli and lasts longer than the Doppler detection. We do not use a pre-cordial Doppler but respond quickly -waxing the bone and flooding the area with irrigation -if patients suddenly begin to clear their throats.
The procedure is performed under local anaesthetic (a mixture of short-and long-lasting) and patients are not routinely given sedatives.
Blood pressure is maintained below 140 mmHg systolic with antihypertensives selected not to interfere with the operation (β-blockers will stop tremor and some e.g. metoprolol 93 can reduce STN bursting).
We use hydralazine and labetalol (when tremor is not an issue). Patients have pneumatic intermittent calf compression and females are catheterised. The opening of the skull deserves attention. Scalp incisions are made to best avoid hardware directly beneath them. 94 This lesson has been adopted from our paediatric neurosurgical colleagues and their vast experience with shunts but has been lost to some surgeons who continue to use a straight incision (best suited for lesions) even after transitioning to DBS. Care is taken to preserve the arachnoid when opening the dura. The arachnoid is then coagulated down onto the pia and 'spot welded' so the pial incision does not cause a cerebrospinal fluid (CSF) leak. We believe this simple technique reduces brain shift during surgery. 95 After the electrodes are placed through the brain, the burr hole is sealed with Surgifoam ® (Ferrosan Medical Devices, Soeborg, Denmark) and Tisseel ® (Baxter, Vienna, Austria).
Thalamic Deep Brain Stimulation
The thalamic target is the Vim. Some authors 96 describe a deeper target, the zona incerta, which probably catches the fibres heading to the Vim as a smaller bundle. Recent diffusion tensor imaging suggests that the dentatorubrothalamic fibres can be targeted at a variety of levels to obtain a similar tremor reduction. 97 The Vim lies immediately in front of the sensory ventral caudal (Vc) nucleus and can be estimated from its position relative to the MCP. Direct visualisation, although described by our group, 98 has not become popular with conventional MRI. All our intra-operative electrophysiology is performed with macroelectrode stimulation. We acknowledge that micro-electrode recording adds to the scientific discoveries in our field but are not convinced it adds any accuracy to this operation (it can certainly add morbidity).
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The deepest point for the Vim nucleus (and thus its target for the tip of the DBS electrode) is as follows:
• X (lateral) = 11 mm from edge of third ventricle;
• Patients receive antibiotics before surgery and for 24 hours after.
Pallidal Deep Brain Stimulation
The pallidal target is the GPi. The GPi lies immediately above the optic tract and lateral to the internal capsule. Direct visualisation can guide targeting, 71, 79, 88, 101, 102 although many groups still use co-ordinates relative to the MCP. As in the thalamus, we have not found that micro-electrode recording has added to the operation and a meta-analysis suggested it increased the risk of complications.
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The deepest point for the GPi nucleus (and thus its target for the tip of the DBS electrode) relative to the MCP is as follows:
• X (lateral) = 21 mm lateral from the midline;
• Y (anteroposterior) = 2 mm anterior; and
• Z (vertical) = 4-6 mm below.
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We adjust the initial anatomical target to be as inferior as possible but still 2 mm superior to the dorsolateral edge of the optic tract.
We prefer to approach at an angle of 65° up from the AC-PC line in the sagittal plane and often are 10-20° lateral in the coronal plane in order to come through the middle frontal gyrus and avoid sulci.
Intra-operative electrophysiological confirmation of the GPi target is performed with a macroelectrode (Radionics 1.5 mm exposed tip, 1.8 mm diameter). The stimulation parameters will vary between equipment but 50 Hz, 1 ms pulses at 3.0-5.0 V (typically 900 Ω) will cause contralateral hand or face contractions (or paraesthesia) due to internal capsule stimulation. There is no symptom to titrate the DBS against because patients will not have dyskinesia during surgery, since their PD medications will have been held from the night before. The macroelectrode can then be replaced by a permanent DBS electrode under fluoroscopic guidance and locked in place. Placement of the INS is the same as for the thalamic procedure described above.
Subthalamic Nucleus Deep Brain Stimulation
The STN target is relatively small [103] [104] [105] and its dorsolateral portion appears to be the ideal target. [106] [107] [108] [109] [110] Many groups use direct visualisation of the target with T2-weighted magnetic resonance images that show the presumed location of the nucleus as dark, low signal intensity because of its expected iron content. 72, 75, 111 We have used a combination of micro-electrode recording and macrostimulation to electrophysiologically confirm the ideal electrode site.
The deepest point for the STN target (and thus its target for the tip of the DBS electrode) relative to the MCP is as follows:
• X (lateral) = 11 mm lateral from the midline;
• prospective randomised blinded study 121 and prospective long-term follow-up studies. 62, 139 The specific complication with GPi DBS can be neuropsychological changes, disturbance in sleep pattern and dysarthria; however, these are relatively infrequent. 140 
STN DBS for PD was first reported by the Grenoble group in France.
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A later randomised trial showed that STN DBS was more effective than the best medical therapy in advanced PD with significant improvement in the UPDRS-III and Parkinson's disease questionnaire (PDQ-39) (Quality of life). 31 Benefits are consistent between the groups and can persist for four to ten years. 31, 121, 139, 141 STN DBS improves all the cardinal dopaminergic symptoms. It requires a significant reduction in dopaminergic medication and therefore reduces medicine-related adverse effects. 14, [142] [143] [144] In a meta-analysis of outcomes following STN DBS, 145 it was found that the average decrease in absolute UPDRS II (activities of daily living) was 13.35.
The average reduction in L-dopa equivalents following surgery was 55.9 % and the average reduction in dyskinesia following surgery was 69.1 %.
It was also noted that the average decrease in the duration of daily off periods was 68. 
